Kane Biotech to host commercial update webcast on September 16
Board Chair Philip Renaud, wound-care surgeon Dr. John C. Lantis and Interim CEO Dr. Robert Huizinga will discuss Kane’s commercial progress, clinical relevance and operational priorities on September 16 webcast.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.